Difference between revisions of "Porton Capital"
Tom Griffin (talk | contribs) m (typo) |
Tom Griffin (talk | contribs) (People) |
||
| Line 1: | Line 1: | ||
[[Porton Capital]] Ltd is a financial management company specialising in the offshore mutual fund sector and development capital for technology commercialisation ventures.<ref>[http://www.portoncapital.com/web/index.php Porton Capital], homepage, accessed 17 October 2011.</ref> | [[Porton Capital]] Ltd is a financial management company specialising in the offshore mutual fund sector and development capital for technology commercialisation ventures.<ref>[http://www.portoncapital.com/web/index.php Porton Capital], homepage, accessed 17 October 2011.</ref> | ||
| + | |||
| + | ==People== | ||
| + | *[[Harvey Boulter]] - Chief Executive<ref>Rupert Neate, [http://www.guardian.co.uk/society/2011/jun/20/3m-countersues-mrsa-superbug-row 3M countersues as MRSA row becomes toxic], guardian.co.uk, 20 June 2011.</ref> | ||
==Notes== | ==Notes== | ||
Revision as of 15:33, 17 October 2011
Porton Capital Ltd is a financial management company specialising in the offshore mutual fund sector and development capital for technology commercialisation ventures.[1]
People
- Harvey Boulter - Chief Executive[2]
Notes
- ↑ Porton Capital, homepage, accessed 17 October 2011.
- ↑ Rupert Neate, 3M countersues as MRSA row becomes toxic, guardian.co.uk, 20 June 2011.
